Current position:Home >Product >
Hexacosanamide, N-[(1S,2R)-2-hydroxy-1-(hydroxymethyl)heptadecyl]- (9C I)
Hexacosanamide, N-[(1S,2R)-2-hydroxy-1-(hydroxymethyl)heptadecyl]- (9C I)(182362-38-5)
- Name: Hexacosanamide, N-[(1S,2R)-2-hydroxy-1-(hydroxymethyl)heptadecyl]- (9C I)
- Synonyms:Hexacosanamide,N-[2-hydroxy-1-(hydroxymethyl)heptadecyl]-, [R-(R*,S*)]-
- Molecular Formula:C44H89 N O3
- Molecular Weight:680.18
- CAS Registry Number:182362-38-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.182362-38-5 Hexacosanamide, N-[(1S,2R)-2-hydroxy-1-(hydroxymethyl)heptadecyl]- (9C I)
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.182362-38-5 C26-Dihydro Ceramide
Assay:97% Appearance:crystalline powder Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 5445-69-2/N-[[4-[bis(2-chloroethyl)amino]phenyl]methylideneamino]-2-phenyl-quinoline-4-carboxamide
- 67422-14-4/Proinsulin (human)
- 130800-90-7/Sipatrigine
- 82422-46-6/2-Trifluoroacetamidobenzenesulfonyl fluoride
- 155164-55-9/4,5-dichloro-2-propylsulfonyl-pyridazin-3-one
- 6884-54-4/8-[3-(10H-Phenothiazin-10-yl)propyl]-3,8-diazabicyclo[3.2.1]octane-3-ethanol
- 35057-44-4/[[(2R,3R,4R,5R)-5-(6-amino-2-chloro-purin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]methylphosphonic acid
- 2966-03-2/3,5,7,8-tetrachloro-2,2,3,4,4,5,6,6,7,8,8-undecafluorooctanoic acid - cyclohexanamine (1:1)
- 289-75-8/Antimonin
- 161364-85-8/ethyl 3-[(2R)-2-[(2-methoxyphenoxy)methyl]pyrrolidin-1-yl]-3-oxo-propa noate
- 100762-36-5/iso TC 1
- 832-65-5/Antiarolaldehyde
- 71368-69-9/4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 1-bromo-6-phenyl-
- 65045-84-3/S,S-bis(4-dodecylphenyl) hydrogen phosphorodithioate
- 87425-68-1/7-Bromobenz(a)anthracene 3,4-dihydrodiol
- 607-27-2/2-[(4-nitrophenyl)hydrazono]naphthalen-1(2H)-one
- 105118-81-8/Spiro[10,12:19,22a-dimethano-4H,5H,22aH-oxireno[8,9][1,6,12]trioxacyclooctadecino[3,4-d][1]benzopyran-11(10H),2'-oxirane]-2,14(1aH,17H)-dione,19-acetyl-6,8a,11a,12,18,19,21,22-octahydro-23-hydroxy-7,11a-dimethyl-,(1aS,4aR,8aR,10R,11S,11aS,12R,15Z,19S,22aR,23S)- (9CI)
- 18397-57-4/ethyl 2,4-dicyano-3-methylbutanoate
- 184288-94-6/Betavulgaroside IX
- 182362-38-5/Hexacosanamide, N-[(1S,2R)-2-hydroxy-1-(hydroxymethyl)heptadecyl]- (9C I)
- 107227-59-8/dibenzo[b,e][1,4]dioxin, bromide chloride (1:1:2)
- 67906-35-8/3-[[4-[(2,6-Dibromo-4-nitrophenyl)azo]-3-methylphenyl]ethylamino]propanenitrile
- 28446-41-5/9-(2,5-anhydropentofuranosyl)-9H-purin-6-amine
- 227086-12-6/2(5H)-Furanone,5-methyl-3-[(2R,8R,13R)-2,8,13-trihydroxy-13-[(2S,2'S,5R,5'R)-octahydro-5'-[(1S)-1-hydroxyundecyl][2,2'-bifuran]-5-yl]tridecyl]-,(5S)-
- 65186-51-8/4-Oxabicyclo[12.2.1]heptadeca-7,9-diene-17-carboxaldehyde,6-[[(6-deoxy-2,3-di-O-methyl-b-D-allopyranosyl)oxy]methyl]-15-[[3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-a-L-ribo-hexopyranosyl)-3-(dimethylamino)-b-D-glucopyranosyl]oxy]-5-ethyl-1-hydroxy-8,12,16-trimethyl-3,11-dioxo-(9CI)
- 23892-69-5/1-(2-{[(4-chlorophenyl)(phenyl)methyl]sulfanyl}ethyl)-4-phenylpiperazine ethanedioate (1:1)
- 55654-71-2/N-(indol-3-ylglyoxylyl)benzylamine
- 55598-33-9/Protein (bacteriophage Pf1 coat)
- 1031-38-5/[5-(hydroxymethyl)-2-methyl-2-phenyl-1,3-dioxan-5-yl]-N,N,N-trimethylmethanaminium bromide
- 430-85-3/1,1-DIBROMODIFLUOROETHYLENE